BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32180663)

  • 21. Drug-drug interactions in hospitalized cardiac patients.
    Mateti U; Rajakannan T; Nekkanti H; Rajesh V; Mallaysamy S; Ramachandran P
    J Young Pharm; 2011 Oct; 3(4):329-33. PubMed ID: 22224041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece.
    Spanakis M; Ioannou P; Tzalis S; Chouzouri F; Patelarou E; Kofteridis DP; Antoniou KM; Schiza SE; Patelarou A; Tzanakis N
    Adv Respir Med; 2023 Feb; 91(1):74-92. PubMed ID: 36825942
    [No Abstract]   [Full Text] [Related]  

  • 23. Identifying and Communicating Clinically Meaningful Drug-Drug Interactions.
    Nelson SD; LaFleur J; Hunter E; Archer M; Steinvoort C; Maden C; Oderda GM
    J Pharm Pract; 2016 Apr; 29(2):110-5. PubMed ID: 25107417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug-drug interactions in multicentre polypathological polymedicated patients].
    Galindo-Ocaña J; Gil-Navarro MV; García-Morillo JS; Bernabeu-Wittel M; Ollero-Baturone M; Ortiz-Camuñez MA
    Rev Clin Esp; 2010 Jun; 210(6):270-8. PubMed ID: 20434722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia.
    Assefa YA; Kedir A; Kahaliw W
    Integr Pharm Res Pract; 2020; 9():1-9. PubMed ID: 32021833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.
    Oshikoya KA; Oreagba IA; Lawal S; Awodele O; Ogunleye OO; Senbanjo IO; Olayemi SO; Ezeaka VC; Temiye EO; Adeyemo TA; Opanuga O; Lesi OA; Akanmu SA
    HIV AIDS (Auckl); 2014; 6():49-59. PubMed ID: 24741328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of clinically manifested drug interactions in hospitalized patients: A systematic review and meta-analysis.
    Gonzaga de Andrade Santos TN; Mendonça da Cruz Macieira G; Cardoso Sodré Alves BM; Onozato T; Cunha Cardoso G; Ferreira Nascimento MT; Saquete Martins-Filho PR; Pereira de Lyra D; Oliveira Filho AD
    PLoS One; 2020; 15(7):e0235353. PubMed ID: 32609783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
    Straubhaar B; Krähenbühl S; Schlienger RG
    Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Drug-Drug Interactions in Hospitalized Medical Patients: Data From Low Resource Settings.
    Rashid K; Khan Y; Ansar F; Waheed A; Aizaz M
    Cureus; 2021 Aug; 13(8):e17336. PubMed ID: 34557372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico.
    Morales-Ríos O; Jasso-Gutiérrez L; Reyes-López A; Garduño-Espinosa J; Muñoz-Hernández O
    PLoS One; 2018; 13(1):e0190882. PubMed ID: 29304072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
    Rodrigues J; Marques P; Gomes C; Portela C
    Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.
    Thomas L; Birangal SR; Ray R; Sekhar Miraj S; Munisamy M; Varma M; S V CS; Banerjee M; Shenoy GG; Rao M
    Ther Adv Drug Saf; 2021; 12():20420986211041277. PubMed ID: 34471515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 37. Potential drug-drug interactions among prescriptionsfor elderly patients in primary health care.
    Gören Z; J Demirkapu M; Akpinar Acet G; Çali S; Gülçebi Idriz Oğlu M
    Turk J Med Sci; 2017 Feb; 47(1):47-54. PubMed ID: 28263519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real world co-prescribing contraindicated drugs with fluconazole and itraconazole.
    Je NK; Youm S; Chun P
    Pharmacoepidemiol Drug Saf; 2023 Jul; 32(7):752-762. PubMed ID: 36812157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.
    Wang Y; Bahar MA; Jansen AME; Kocks JWH; Alffenaar JC; Hak E; Wilffert B; Borgsteede SD
    J Antimicrob Chemother; 2019 Oct; 74(10):2848-2864. PubMed ID: 31127283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy.
    Scondotto G; Pojero F; Pollina Addario S; Ferrante M; Pastorello M; Visconti M; Scondotto S; Casuccio A
    Aging Clin Exp Res; 2018 Jan; 30(1):81-87. PubMed ID: 28405956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.